Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Frieri

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The American Journal of Gastroenterology|July 14, 2000
Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del RettoG Frieri, M T Pimpo, G Palumbo, et al.
Alimentary Pharmacology & Therapeutics|May 8, 1999
Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del RettoG Frieri, M T Pimpo, A Andreoli, et al.
Hepato-Gastroenterology|November 1, 1996
Effects of cisapride on abnormally prolonged endogastric alkalinity time and delayed gastric emptying in cirrhotic patientsM T Pimpo, G Frieri, P Saltarelli, et al.
Clinical and Experimental Immunology|February 5, 1999
Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patientsR Giacomelli, A Passacantando, G Frieri, et al.
Annals of the Rheumatic Diseases|August 7, 2004
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestationsS Generini, R Giacomelli, R Fedi, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The American Journal of Gastroenterology|July 14, 2000
Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del RettoG Frieri, M T Pimpo, G Palumbo, et al.
Alimentary Pharmacology & Therapeutics|May 8, 1999
Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del RettoG Frieri, M T Pimpo, A Andreoli, et al.
Hepato-Gastroenterology|November 1, 1996
Effects of cisapride on abnormally prolonged endogastric alkalinity time and delayed gastric emptying in cirrhotic patientsM T Pimpo, G Frieri, P Saltarelli, et al.
Clinical and Experimental Immunology|February 5, 1999
Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patientsR Giacomelli, A Passacantando, G Frieri, et al.
Annals of the Rheumatic Diseases|August 7, 2004
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestationsS Generini, R Giacomelli, R Fedi, et al.
Pageof 5